Skip to main content
Diamines & Chemicals Ltd. logo

Diamines & Chemicals Ltd. — Investor Relations & Filings

Ticker · DIAMINESQ ISIN · INE591D01014 LEI · 335800AQNIZET87LXI95 BSE.NS Manufacturing
Open in API
Filings indexed 873 across all filing types
Latest filing 2026-03-17 Board/Management Inform…
Country IN India
Listing BSE.NS DIAMINESQ

About Diamines & Chemicals Ltd.

https://dacl.co.in/

Diamines & Chemicals Ltd. specializes in the production of ethylene amines and related chemical intermediates. The company’s core product portfolio includes Ethylenediamine (EDA), Diethylenetriamine (DETA), Triethylenetetramine (TETA), Tetraethylenepentamine (TEPA), and Piperazine. These specialty chemicals are utilized across diverse sectors, including pharmaceuticals, agrochemicals, polyamide resins, and water treatment. The firm operates integrated manufacturing facilities designed for the synthesis of high-purity organic compounds. By leveraging advanced chemical processes, it provides essential raw materials for applications in oilfield chemicals, textile auxiliaries, and paper chemicals. The organization maintains a focus on technical excellence and process innovation to meet the stringent requirements of global supply chains.

Recent filings

Filing Released Lang Actions
Diamines & Chemicals Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/03/2026 ,inter alia, to consider and approve conversion of warrants ....
Board/Management Information Classification · 95% confidence The document is a notice of a meeting of the Board of Directors scheduled to consider and approve the conversion of warrants into equity shares and other business. It references compliance with Regulation 29 and Chapter IV of SEBI (LODR) regulations, which govern disclosures related to board meetings and corporate actions. The document is short (1498 characters) and serves as an announcement of a board meeting rather than a detailed report or financial statement. It does not contain financial data, audit information, or detailed management discussion. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of changes or meetings related to the company's board or senior management activities.
2026-03-17 English
Copy of Newspaper Publication
Interim / Quarterly Report Classification · 95% confidence The document contains a notice to shareholders regarding the opening of a special window for transfer and dematerialisation of physical securities, referencing SEBI regulations and circulars. It includes an extract of unaudited financial results for the quarter and nine months ended December 31, 2025, with financial figures and notes. The document is over 12,000 characters, indicating substantive content rather than a brief announcement. The presence of quarterly financial results with actual financial data and notes suggests this is a comprehensive interim/quarterly financial report. There is no indication that this is merely an announcement of a report or a certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). 9M 2025
2026-02-13 English
We submit herewith copies of notice published in Newspapers regarding intimation to shareholder for opening of special window for transfer and dematerialisation of Physical shares.
Interim / Quarterly Report Classification · 95% confidence The document contains a notice to shareholders regarding the opening of a special window for transfer and dematerialisation of physical securities, referencing SEBI regulations and circulars. It also includes a statement of financial results for the nine months ended December 31, 2025, with detailed financial figures and notes indicating board approval. The presence of detailed financial results for a period shorter than a full fiscal year (nine months) and the mention of review and audit status aligns with an Interim / Quarterly Report. The document is substantial in length (15,000 characters) and contains actual financial data, not merely an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). 9M 2026
2026-02-13 English
Disclosure of Regulation 32(1) of the SEBI (LODR) Regulations, 2015 for the Quarter ended on December 31, 2025
Regulatory Filings Classification · 95% confidence The document is a disclosure made pursuant to Regulation 32(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically for the quarter ended December 31, 2025. It contains a statement of deviation or variation in the utilization of funds raised through a preferential issue. The content focuses on compliance disclosure about fund usage and does not contain financial statements or detailed financial analysis. It is a regulatory compliance announcement related to fund utilization deviation reporting, not a full financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2026-02-12 English
We submit herewith unaudited Financial Results for the quarter and nine months ended on 31.12.2025
Interim / Quarterly Report Classification · 95% confidence The document is a detailed announcement from the Board of Directors of Diamines and Chemicals Limited dated February 12, 2026. It includes the approval of standalone and consolidated unaudited financial results for the quarter and nine months ended December 31, 2025, along with a Limited Review Report by an independent auditor. The document contains extensive financial data, including revenue, expenses, profit before tax, tax expenses, and other comprehensive income for the specified periods. The presence of unaudited financial results for a quarter and nine months, along with the auditor's review report, indicates this is an Interim / Quarterly Report. The document is not merely an announcement of a report but contains substantive financial data and analysis. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q3 2026
2026-02-12 English
Statement of deviation(s) or variation(s) under Reg. 32
Regulatory Filings Classification · 95% confidence The document is a disclosure pursuant to Regulation 32(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically for the quarter ended December 31, 2025. It contains a statement of deviation or variation in the utilization of funds raised through a preferential issue. The content focuses on compliance and regulatory disclosure about fund usage rather than presenting financial statements or detailed financial performance. The document is relatively short (4800 characters) and serves as a regulatory compliance filing rather than a full financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2026-02-12 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.